BofA analyst Vivek Arya lowered the firm’s price target on Teradyne (TER) to $85 from $100 and keeps an Underperform rating on the shares after having attended the company’s 2025 investor day event, where Teradyne outlined multiple longer-term secular growth vectors. The firm views the company’s calendar year 2026 and 2028 outlooks as “potentially aggressive” and sees much more muted growth opportunities in the key AI compute/memory space, the analyst tells investors in a note recapping the event.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TER:
- Teradyne Positioned for Growth Amid Industry Trends and Strategic Acquisitions
- Teradyne’s Revised Guidance and Trade Uncertainties Prompt Sell Rating by Analyst Shane Brett
- Cautious Outlook on Teradyne Amid Macroeconomic Challenges and Ambitious Growth Targets
- Teradyne price target lowered to $120 from $145 at JPMorgan
- Cathie Wood’s ARK Investment bought 162K shares of Teradyne today